Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
Approval Addresses High Unmet Medical Need and Further Advances Viatris' Innovative Portfolio in Japan PITTSBURGH, Sept. 16, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare has granted...
Covered in this story
What has happened since
- Viatris is up 8.1% since this was published, 34 days ago.
- Associated Bancorp is down 2.3% since this was published, 34 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $VTRS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Viatris →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.